Cargando…

Neurofilaments as Emerging Biomarkers of Neuroaxonal Damage to Differentiate Behavioral Frontotemporal Dementia from Primary Psychiatric Disorders: A Systematic Review

The behavioral variant of frontotemporal dementia (bvFTD) is a clinical syndrome resulting from various causes of neuronal demises associated with frontotemporal lobar degeneration. Symptoms include behavioral and personality changes, social cognitive impairment, and executive function deficits. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davy, Vincent, Dumurgier, Julien, Fayosse, Aurore, Paquet, Claire, Cognat, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146697/ https://www.ncbi.nlm.nih.gov/pubmed/33922390 http://dx.doi.org/10.3390/diagnostics11050754

Ejemplares similares

Association of sleep duration in middle and old age with incidence of dementia
por: Sabia, Séverine, et al.
Publicado: (2021)

Neurofilament light chain: a biomarker for genetic frontotemporal dementia
por: Meeter, Lieke H., et al.
Publicado: (2016)

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

Blood-Based Kinase Assessments in Alzheimer’s Disease
por: Hugon, Jacques, et al.
Publicado: (2018)

Urine as matrix for analysis of neurofilament light chain is not suitable to distinguish frontotemporal dementia from psychiatric diseases
por: van Engelen, Marie-Paule E, et al.
Publicado: (2023)

Cerebrospinal Fluid and Blood Biomarkers of Neuroaxonal Damage in Multiple Sclerosis
por: Dujmovic, Irena
Publicado: (2011)

Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy
por: Kim, Su-Hyun, et al.
Publicado: (2020)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Psychiatric Misdiagnosis in Frontotemporal Dementia
por: Yay Pençe, A., et al.
Publicado: (2022)

Frontotemporal dementia is the leading cause of “true” A−/T+ profiles defined with Aβ(42/40) ratio
por: Pouclet-Courtemanche, Hélène, et al.
Publicado: (2019)

Exploring Neurofilament Light Chain and Exosomes in the Genetic Forms of Frontotemporal Dementia
por: Zanardini, Roberta, et al.
Publicado: (2022)

Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes
por: Ooi, Suyi, et al.
Publicado: (2022)

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice
por: Lilamand, Matthieu, et al.
Publicado: (2022)

Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders
por: Katisko, Kasper, et al.
Publicado: (2019)

Timeline of pain before dementia diagnosis: a 27-year follow-up study
por: Kumaradev, Sushmithadev, et al.
Publicado: (2021)

Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study
por: Sabia, Séverine, et al.
Publicado: (2018)

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
por: Landqvist Waldö, Maria, et al.
Publicado: (2013)

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum
por: Meeter, Lieke H.H., et al.
Publicado: (2018)

Risk prediction models for dementia: role of age and cardiometabolic risk factors
por: Fayosse, Aurore, et al.
Publicado: (2020)

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer’s Disease
por: Paquet, Claire, et al.
Publicado: (2015)

Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study
por: Vrillon, Agathe, et al.
Publicado: (2022)

Neuronal and Neuroaxonal Damage Cerebrospinal Fluid Biomarkers in Autoimmune Encephalitis Associated or Not with the Presence of Tumor
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
por: Rohrer, Jonathan D., et al.
Publicado: (2016)

Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia
por: Spotorno, Nicola, et al.
Publicado: (2020)

Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia
por: Giannini, Lucia A.A., et al.
Publicado: (2023)

Disentangling Clinical Profiles of Apathy in Behavioral Variant Frontotemporal Dementia
por: Godefroy, Valérie, et al.
Publicado: (2022)

Biomarker profiles of Alzheimer’s disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau
por: Lafirdeen, Aysha S. Mohamed, et al.
Publicado: (2019)

Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology
por: Scarioni, Marta, et al.
Publicado: (2020)

Association between kidney function and incidence of dementia: 10-year follow-up of the Whitehall II cohort study
por: Singh-Manoux, Archana, et al.
Publicado: (2022)

The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study
por: Gharbi-Meliani, Amin, et al.
Publicado: (2021)

Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study
por: Sabia, Séverine, et al.
Publicado: (2019)

Frontotemporal dementia subtypes based on behavioral inhibition deficits
por: Godefroy, Valérie, et al.
Publicado: (2021)

Plasma Neurofilament Light Is Not Associated with Ongoing Neuroaxonal Injury or Cognitive Decline in Perinatally HIV Infected Adolescents: A Brief Report
por: van der Post, Julie, et al.
Publicado: (2022)

Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients
por: Moser, Tobias, et al.
Publicado: (2021)

The role of neurofilament light in genetic frontotemporal lobar degeneration
por: Zetterberg, Henrik, et al.
Publicado: (2022)

Comparison of the predictive accuracy of multiple definitions of cognitive impairment for incident dementia: a 20-year follow-up of the Whitehall II cohort study
por: Machado-Fragua, Marcos D, et al.
Publicado: (2021)

Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes
por: Pijnenburg, Yolande A.L., et al.
Publicado: (2015)

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2021)

Shared genetic links between frontotemporal dementia and psychiatric disorders
por: Li, Chunyu, et al.
Publicado: (2022)

Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia
por: Bussy, Aurélie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4d4p3fnoaj32bfsqneooofgdvf